ROCK (Gibraltar Industries, Inc.) Stock Analysis - SEC Filings

Gibraltar Industries, Inc. (ROCK) is a publicly traded Industrials sector company. As of May 21, 2026, ROCK trades at $35.15 with a market cap of $1.05B and a P/E ratio of -7.76. ROCK moved +3.96% today. Year to date, ROCK is -30.94%; over the trailing twelve months it is -42.69%. Its 52-week range spans $33.56 to $75.08. Analyst consensus is buy with an average price target of $55.00. Rallies surfaces ROCK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find ROCK SEC filings?

Rallies organizes ROCK SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

ROCK Key Metrics

Key financial metrics for ROCK
MetricValue
Price$35.15
Market Cap$1.05B
P/E Ratio-7.76
EPS$-4.46
Dividend Yield0.05%
52-Week High$75.08
52-Week Low$33.56
Volume0
Avg Volume0
Revenue (TTM)$1.25B
Net Income$-132.98M
Gross Margin25.23%

Latest ROCK News

Recent ROCK Insider Trades

  • Bosway William T bought 1.00K (~$41.37K) on Mar 13, 2026.
  • METCALF JAMES S bought 12.44K (~$502.17K) on Mar 10, 2026.
  • Bosway William T bought 1.50K (~$59.29K) on Mar 10, 2026.

ROCK Analyst Consensus

1 analysts cover ROCK: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $55.00.

Common questions about ROCK

Where can I find ROCK SEC filings?
Rallies organizes ROCK SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show ROCK 10-K and 10-Q filings?
Rallies organizes ROCK SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is ROCK research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ROCK. It does not provide personalized investment advice.
ROCK

ROCK